Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Revenue	$ 1,667	$ 461	$ 2,269	$ 1,187
Cost of revenues	269	6	300	28
Gross profit	1,398	455	1,969	1,159
Sales and marketing expenses	47	215	108	420
General and administrative expenses	665	913	1,471	1,913
Research and development costs	172	259	384	593
Operating income (loss)	514	(932)	6	(1,767)
Loss on extinguishment of debt	0	(27,479)	0	(27,479)
Gain/(loss) from change in fair value of hybrid financial instruments	(29,569)	36,773	(22,795)	5,603
Gain/(loss) from change in fair value of derivative liability - warrants	289	42,409	3,411	921
Gain/(loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures	(1,849)	75,351	(2,149)	(14,298)
Other Income	227	0	227	0
Interest (expense) / income	16	(2,003)	16	(4,395)
Net income (loss) available to common shareholders	(30,372)	124,119	(21,284)	(41,415)
Comprehensive income (loss):
Net income (loss)	(30,372)	124,119	(21,284)	(41,415)
Other comprehensive gain/(loss) - investment in GmbH and foreign currency adjustment	(223)	(8)	(334)	(15)
Comprehensive income (loss):	$ (30,595)	$ 124,111	$ (21,618)	$ (41,430)
Net income (loss) per share, basic and diluted:
Basic (in dollars per share)	$ (0.007)	$ 0.11	$ (0.007)	$ (0.13)
Fully diluted (in dollars per share)	$ (0.007)	$ 0	$ (0.007)	$ (0.13)
Weighted average number of common shares:
Basic (in shares)	4,057,691,643	1,148,526,738	3,230,324,614	326,414,797
Fully diluted (in shares)	4,057,691,643	8,113,106,249	3,230,324,614	326,414,797